Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.
Guidelines for the diagnosis and treatment of gastroesophageal reflux disease (GERD) were published in 1995 and updated in 1999. These and other guidelines undergo periodic review. Advances continue to be made in the area of GERD, leading us to review and revise previous guideline statements. GERD is defined as symptoms or mucosal damage produced by the abnormal reflux of gastric contents into the esophagus. These guidelines were developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee, and approved by the Board of Trustees. Diagnostic guidelines address empiric therapy and the use of endoscopy, ambulatory reflux monitoring, and esophageal manometry in GERD. Treatment guidelines address the role of lifestyle changes, patient directed (OTC) therapy, acid suppression, promotility therapy, maintenance therapy, antireflux surgery, and endoscopic therapy in GERD. Finally, there is a discussion of the rare patient with refractory GERD and a list of areas in need of additional study.
DeVault
Kenneth R
KR
Department of Medicine, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Castell
Donald O
DO
D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D004724:Endoscopy; D004947:Esophagus / Q000503:physiopathology; D005764:Gastroesophageal Reflux / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008019:Life Style; D008365:Manometry; D018670:Monitoring, Ambulatory; D012648:Self Care
D000897:Anti-Ulcer Agents